Who we are.
We are motivated by a vision of the world where people live free from disease and hunger. We believe that developing smart, innovative solutions represents the single best way to achieve these goals.
Our focus is on providing insect control through novel technology that improves human health and food quality through the reduction of insect pest-populations using a biological approach that is safe, sustainable, economic and applicable to many insect-pest species worldwide.
Our solutions can help governments and communities around the world keep people healthy and increase food production, and to do so in a way which is sustainable, environmentally friendly and cost effective.
Where we come from
Oxitec was formed in 2002 by Oxford University Innovation and, in 2015, was acquired by U.S.-based Intrexon.
Since inception, Oxitec has pioneered work on controlling insects that spread disease and damage crops through world-class genetic engineering and the use of self-limiting gene technology. In the mid and late 2000s, Oxitec successfully deployed genetically engineered insects in select locations in the USA, Caribbean, South America, and has continued to grow these projects, expanding to new regions and countries.
In 2016, the World Health Organization (WHO) issued a positive recommendation in support of Oxitec’s self-limiting mosquitoes (OX513A) for a planned pilot in response to the Zika virus outbreak. Oxitec continues to engage with communities around the world that are in need of effective, scalable solutions to combat the dangerous vectors that threaten lives and livelihoods.
Oxitec is a subsidiary of Intrexon Corporation (NYSE: XON), which engineers biology to help solve some of the world’s biggest problems.
Making the difference…
…one person at a time.
Work with us
View our job listings to see where you fit in.